Drug Shortage Report for OGIVRI
Report ID | 120769 |
Drug Identification Number | 02474425 |
Brand name | OGIVRI |
Common or Proper name | TRASTUZUMAB |
Company Name | BIOSIMILAR COLLABORATIONS IRELAND LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TRASTUZUMAB |
Strength(s) | 150MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1VL TRASTUZUMAB |
ATC code | L01XC |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-07-17 |
Estimated end date | 2020-08-04 |
Actual end date | 2020-07-30 |
Shortage status | Resolved |
Updated date | 2020-07-31 |
Company comments | Limited product supply is available on allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | GRANGE PARADE, BALDOYLE INDUSTRIAL ESTATE, DUBLIN 13 DUBLIN, -- IRELAND D13R20R |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-07-31 | English | Compare |
v6 | 2020-07-30 | French | Compare |
v5 | 2020-07-30 | English | Compare |
v4 | 2020-07-22 | French | Compare |
v3 | 2020-07-22 | English | Compare |
v2 | 2020-07-22 | English | Compare |
v1 | 2020-07-22 | English | Compare |
Showing 1 to 7 of 7